Home
RDY
RDY News

Latest Dr. Reddy's Laboratories Ltd (RDY) News on November 7, 2025

MT Newswires

25 days ago

Asian Equities Traded in the US as American Depositary Receipts Soar in Monday Trading

MT Newswires

25 days ago

BNP Paribas Exane Initiates Dr. Reddy's Laboratories at Neutral With $13.18 Price Target

MT Newswires

a month ago

Asian Equities Traded in the US as American Depositary Receipts Fall in Friday Trading; Lose 2.5% for Week

Why Esperion Therapeutics (ESPR) Is Up After $75M Equity Raise and Generic Settlement News

Simply Wall St.

a month ago

Why Esperion Therapeutics (ESPR) Is Up After $75M Equity Raise and Generic Settlement News

MT Newswires

a month ago

Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

MT Newswires

a month ago

Sector Update: Health Care Stocks Gain Late Afternoon

MT Newswires

a month ago

Sector Update: Health Care Stocks Gain Friday Afternoon

MT Newswires

a month ago

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

MT Newswires

a month ago

Esperion Therapeutics Settles Patent Lawsuit Against Dr. Reddy's Laboratories Over Cholesterol Drugs

Esperion Reaches Settlement Agreement with ANDA Filer, Dr. Reddy’s Laboratories, Not to Market Generic Versions of NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Prior to April 19, 2040

GlobeNewswire

a month ago

Esperion Reaches Settlement Agreement with ANDA Filer, Dr. Reddy’s Laboratories, Not to Market Generic Versions of NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Prior to April 19, 2040

MT Newswires

a month ago

Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires

2 months ago

Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires

2 months ago

Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading

MT Newswires

3 months ago

Asian Equities Traded in the US as American Depositary Receipts Surge in Friday Trading

[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire

3 months ago

[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

MT Newswires

3 months ago

Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Thursday Trading

MT Newswires

3 months ago

Asian Equities Traded in the US as ADRs Fall in Wednesday Trading

MT Newswires

3 months ago

Asian Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading

MT Newswires

3 months ago

Asian Equities Traded in the US as American Depositary Receipts Open Week Flat in Monday Trading

MT Newswires

3 months ago

Asian Equities Traded in the US as American Depositary Receipts Sharply Higher in Wednesday Trading

MT Newswires

3 months ago

Asian Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

MT Newswires

4 months ago

Asian Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Up 5% for Week

MT Newswires

4 months ago

Asian Equities Traded in the US as ADRs Rise in Thursday Trading

MT Newswires

4 months ago

Asian Equities Traded in the US as American Depositary Receipts Slightly Lower in Wednesday Trading

MT Newswires

4 months ago

Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading

MT Newswires

4 months ago

Asian Equities Traded in the US as American Depositary Receipts Lower in Monday Trading

Sage Therapeutics (SAGE) Soars 35.4%: Is Further Upside Left in the Stock?

Zacks

5 months ago

Sage Therapeutics (SAGE) Soars 35.4%: Is Further Upside Left in the Stock?

Personalis (PSNL) Soars 7.3%: Is Further Upside Left in the Stock?

Zacks

5 months ago

Personalis (PSNL) Soars 7.3%: Is Further Upside Left in the Stock?

MT Newswires

5 months ago

Asian Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading

HSBC Upgrades Dr. Reddy’s Laboratories Limited (RDY) to Buy from Hold

Insider Monkey

5 months ago

HSBC Upgrades Dr. Reddy’s Laboratories Limited (RDY) to Buy from Hold

Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)

Business Wire

5 months ago

Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)

Dr Reddy's Laboratories Ltd (RDY) Full Year 2025 Earnings Call Highlights: Record Revenue and ...

GuruFocus.com

6 months ago

Dr Reddy's Laboratories Ltd (RDY) Full Year 2025 Earnings Call Highlights: Record Revenue and ...

RDY Q4 Earnings Beat Estimates, Generics Revenues Rise Y/Y, Stock Up

Zacks

6 months ago

RDY Q4 Earnings Beat Estimates, Generics Revenues Rise Y/Y, Stock Up

Morningstar Research

6 months ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy’s Q4 & Full Year FY25 Financial Results

Business Wire

6 months ago

Dr. Reddy’s Q4 & Full Year FY25 Financial Results

Morningstar Research

6 months ago

Analyst Report: Dr. Reddy's Laboratories Limited

MT Newswires

7 months ago

Dr Reddy's Says Reported Job Cuts 'Factually Incorrect'

Dr. Reddy’s Laboratories (RDY): Among the Best Indian Stocks to Buy According to Billionaires

Insider Monkey

7 months ago

Dr. Reddy’s Laboratories (RDY): Among the Best Indian Stocks to Buy According to Billionaires

Morningstar Research

7 months ago

Analyst Report: Dr. Reddy's Laboratories Limited

Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia

PR Newswire

7 months ago

Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia

Alvotech and Dr. Reddy’s Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

Business Wire

8 months ago

Alvotech and Dr. Reddy’s Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

Dr. Reddy’s announces recall of Levetiracetam 0.75% Sodium Chloride injection

TipRanks

8 months ago

Dr. Reddy’s announces recall of Levetiracetam 0.75% Sodium Chloride injection

Dr. Reddy's Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., due to Mislabeling of Infusion Bag

Business Wire

8 months ago

Dr. Reddy's Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., due to Mislabeling of Infusion Bag

Is Dr. Reddy’s Laboratories Limited (RDY) the Best Weight Loss Drug Stock to Buy According to Analysts?

Insider Monkey

8 months ago

Is Dr. Reddy’s Laboratories Limited (RDY) the Best Weight Loss Drug Stock to Buy According to Analysts?

Is Dr. Reddy’s Laboratories Limited (RDY) the Best Low Price Pharma Stock to Invest In Right Now?

Insider Monkey

8 months ago

Is Dr. Reddy’s Laboratories Limited (RDY) the Best Low Price Pharma Stock to Invest In Right Now?

Dr Reddy’s and Shanghai Henlius sign agreement for HLX15

Pharmaceutical Technology

9 months ago

Dr Reddy’s and Shanghai Henlius sign agreement for HLX15

Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe

Business Wire

9 months ago

Dr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe

Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.

PR Newswire

9 months ago

Henlius and Dr. Reddy's Ink Licensing Deal for HLX15 (investigational daratumumab biosimilar) Expansion in Europe and the U.S.

RDY Q3 Earnings Match Estimates, Generics Revenues Rise Y/Y, Stock Down

Zacks

9 months ago

RDY Q3 Earnings Match Estimates, Generics Revenues Rise Y/Y, Stock Down

Dr Reddy's Laboratories Ltd (RDY) Q3 2025 Earnings Call Highlights: Record Revenue Growth ...

GuruFocus.com

9 months ago

Dr Reddy's Laboratories Ltd (RDY) Q3 2025 Earnings Call Highlights: Record Revenue Growth ...

Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business

Benzinga

9 months ago

Dr Reddy's Laboratories Q3 Earnings: Double-Digit Growth Aided By Newly Acquired Nicotine Replacement Business

Morningstar Research

9 months ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy’s Q3 & 9MFY25 Financial Results

Business Wire

9 months ago

Dr. Reddy’s Q3 & 9MFY25 Financial Results

Dr. Reddy’s Laboratories Allocates Equity Shares to Employees

TipRanks

a year ago

Dr. Reddy’s Laboratories Allocates Equity Shares to Employees

Dr. Reddy’s Boosts Workforce with Equity Allotment

TipRanks

a year ago

Dr. Reddy’s Boosts Workforce with Equity Allotment

Why Dr. Reddy’s Laboratories Limited (RDY) Is One of the Most Profitable Pharmaceutical Stocks Right Now?

Insider Monkey

a year ago

Why Dr. Reddy’s Laboratories Limited (RDY) Is One of the Most Profitable Pharmaceutical Stocks Right Now?

Dr. Reddy’s Launches Innovative Cancer Drug in India

TipRanks

a year ago

Dr. Reddy’s Launches Innovative Cancer Drug in India

Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma

Business Wire

a year ago

Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma

Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market

Business Wire

a year ago

Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market

Dr. Reddy’s Gains Strong Rating Amid Robust Growth

TipRanks

a year ago

Dr. Reddy’s Gains Strong Rating Amid Robust Growth

Dr. Reddy's Q2 Earnings Miss Estimates, Global Generics Revenues Grow

Zacks

a year ago

Dr. Reddy's Q2 Earnings Miss Estimates, Global Generics Revenues Grow

Dr Reddy's Laboratories Ltd (RDY) (HY 2025) Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

a year ago

Dr Reddy's Laboratories Ltd (RDY) (HY 2025) Earnings Call Highlights: Strong Revenue Growth and ...

Morningstar Research

a year ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy’s Q2 & H1FY25 Financial Results

Business Wire

a year ago

Dr. Reddy’s Q2 & H1FY25 Financial Results

Morningstar Research

a year ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy's Named by Science Magazine in Top 20 Global Pharma Employers List for Third Consecutive Year

Business Wire

a year ago

Dr. Reddy's Named by Science Magazine in Top 20 Global Pharma Employers List for Third Consecutive Year

Dr. Reddy’s Launches Comprehensive Menopause Support Program and Training for Employees During Menopause Awareness Month

Business Wire

a year ago

Dr. Reddy’s Launches Comprehensive Menopause Support Program and Training for Employees During Menopause Awareness Month

Dr. Reddy’s Subsidiary Triumphs in CAR-T Cell Therapy Trial

TipRanks

a year ago

Dr. Reddy’s Subsidiary Triumphs in CAR-T Cell Therapy Trial

Dr. Reddy’s Laboratories Limited (RDY): Among the Best Indian Stocks for the Next 10 Years

Insider Monkey

a year ago

Dr. Reddy’s Laboratories Limited (RDY): Among the Best Indian Stocks for the Next 10 Years

Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India’s First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma

Business Wire

a year ago

Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India’s First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma

Dr. Reddy’s Unveils New Danish Subsidiary

TipRanks

a year ago

Dr. Reddy’s Unveils New Danish Subsidiary

Dr. Reddy’s signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries

Business Wire

a year ago

Dr. Reddy’s signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries

Dr. Reddy’s Acquires Global NRT Leader Nicotinell

TipRanks

a year ago

Dr. Reddy’s Acquires Global NRT Leader Nicotinell

Dr. Reddy’s Expands Portfolio with $620M Investment

TipRanks

a year ago

Dr. Reddy’s Expands Portfolio with $620M Investment

Dr Reddy’s, Aurigene and Kainomyx to co-develop anti-malarials

Pharmaceutical Technology

a year ago

Dr Reddy’s, Aurigene and Kainomyx to co-develop anti-malarials

Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug

Business Wire

a year ago

Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug

Morningstar Research

a year ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy’s Receives Positive CHMP Opinion From European Medicines Agency for Its Proposed Rituximab Biosimilar

Business Wire

a year ago

Dr. Reddy’s Receives Positive CHMP Opinion From European Medicines Agency for Its Proposed Rituximab Biosimilar

Dr. Reddy's (RDY) Q1 Earnings Miss Estimates, Revenues Beat

Zacks

a year ago

Dr. Reddy's (RDY) Q1 Earnings Miss Estimates, Revenues Beat

Dr. Reddy’s Q1FY25 Financial Results

Business Wire

a year ago

Dr. Reddy’s Q1FY25 Financial Results

Morningstar Research

a year ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business

Business Wire

a year ago

Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business

Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing Capabilities

Business Wire

a year ago

Aurigene Pharmaceutical Services Limited, a Global CRDMO, Announces the Opening of Its Biologics Facility Offering Process Development and Clinical Scale Manufacturing Capabilities

Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America

Business Wire

a year ago

Dr. Reddy's Laboratories Announces the Appointment of Milan Kalawadia to CEO North America

Alvotech and Dr Reddy’s partner to commercialise AVT03

Pharmaceutical Technology

a year ago

Alvotech and Dr Reddy’s partner to commercialise AVT03

Alvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK

Business Wire

a year ago

Alvotech and Dr. Reddy’s Enter Into Collaboration for Commercialization of AVT03 (denosumab), a Biosimilar Candidate to Prolia® & Xgeva® in the U.S., Europe and UK

Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term

Zacks

a year ago

Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term

Morningstar Research

a year ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q4 2024 Earnings Call Transcript

Insider Monkey

a year ago

Dr. Reddy’s Laboratories Limited (NYSE:RDY) Q4 2024 Earnings Call Transcript

Morningstar Research

a year ago

Analyst Report: Dr. Reddy's Laboratories Limited

Dr. Reddy's (RDY) Q4 Earnings Top, North America Sales Grow

Zacks

a year ago

Dr. Reddy's (RDY) Q4 Earnings Top, North America Sales Grow

Dr. Reddy’s Q4 & Full Year FY24 Financial Results

Business Wire

2 years ago

Dr. Reddy’s Q4 & Full Year FY24 Financial Results

Dr. Reddy's Laboratories Announces the Launch of Doxycycline Capsules, 40 mg* in the U.S.

Business Wire

2 years ago

Dr. Reddy's Laboratories Announces the Launch of Doxycycline Capsules, 40 mg* in the U.S.

Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India

GlobeNewswire

2 years ago

Pharmazz Inc. and Dr. Reddy's Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India

Dr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UK

Business Wire

2 years ago

Dr. Reddy's Laboratories launches Versavo® (bevacizumab) in the UK

Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term

Zacks

2 years ago

Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term

Why Doctor Reddy's (RDY) is a Top Momentum Stock for the Long-Term

Zacks

2 years ago

Why Doctor Reddy's (RDY) is a Top Momentum Stock for the Long-Term

Is There Any Hope for Cassava Sciences Stock?

Motley Fool

2 years ago

Is There Any Hope for Cassava Sciences Stock?

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

2 years ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Aptiv to Present at Wolfe Research Global Auto and Auto Tech Conference

Business Wire

2 years ago

Aptiv to Present at Wolfe Research Global Auto and Auto Tech Conference

Share on Social Networks: